Page last updated: 2024-10-30

metformin and Primary Ovarian Insufficiency

metformin has been researched along with Primary Ovarian Insufficiency in 4 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Primary Ovarian Insufficiency: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.

Research Excerpts

ExcerptRelevanceReference
"This study aims to assess the therapeutic effects of a well-known component (puerarin) obtained from a Chinese herb root in patients with polycystic ovary syndrome (PCOS)."9.41Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women. ( Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G, 2021)
"To compare the therapeutic effects of metformin (Met) and laparoscopic ovarian drilling (LOD) in clomiphene and insulin-resistant patients with polycystic ovary syndrome (CIRPCOS)."9.20Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndrome. ( Huang, LP; Wang, JQ; Wang, XH; Xu, Y, 2015)
"This study aims to assess the therapeutic effects of a well-known component (puerarin) obtained from a Chinese herb root in patients with polycystic ovary syndrome (PCOS)."5.41Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women. ( Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G, 2021)
"To compare the therapeutic effects of metformin (Met) and laparoscopic ovarian drilling (LOD) in clomiphene and insulin-resistant patients with polycystic ovary syndrome (CIRPCOS)."5.20Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndrome. ( Huang, LP; Wang, JQ; Wang, XH; Xu, Y, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Navarro-Pando, JM1
Bullón, P1
Cordero, MD1
Alcocer-Gómez, E1
Li, W1
Hu, H1
Zou, G1
Ma, Z1
Liu, J1
Li, F1
Pan, ML1
Chen, LR1
Tsao, HM1
Chen, KH1
Wang, XH1
Wang, JQ1
Xu, Y1
Huang, LP1

Trials

2 trials available for metformin and Primary Ovarian Insufficiency

ArticleYear
Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.
    Medicine, 2021, May-28, Volume: 100, Issue:21

    Topics: Administration, Oral; Adolescent; Adult; China; Cholesterol; Cyproterone Acetate; Drug Administratio

2021
Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndrome.
    Archives of gynecology and obstetrics, 2015, Volume: 291, Issue:5

    Topics: Adult; Clomiphene; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Laparoscopy; Me

2015

Other Studies

2 other studies available for metformin and Primary Ovarian Insufficiency

ArticleYear
Is AMP-Activated Protein Kinase Associated to the Metabolic Changes in Primary Ovarian Insufficiency?
    Antioxidants & redox signaling, 2020, 11-20, Volume: 33, Issue:15

    Topics: AMP-Activated Protein Kinases; Biomarkers; Case-Control Studies; Disease Management; Disease Suscept

2020
Polycystic ovarian syndrome and the risk of subsequent primary ovarian insufficiency: a nationwide population-based study.
    Menopause (New York, N.Y.), 2017, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Databases, Factual; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ov

2017